Výsledky vyhľadávania - "Pulte ED"

The prognostic significance of incomplete hematological recovery in pediatric patients with low/intermediate risk AML and negative MRD after induction 1.

Autori: Shahin, Nessma M. Hammad, Mahmoud Hafez, Hanafy a ďalší

Zdroj: Frontiers in Oncology; 2025, p1-11, 11p

Predmety: ACUTE myeloid leukemia, PROGNOSIS, HEMATOLOGIC malignancies, TREATMENT effectiveness, HEMATOPOIESIS, PEDIATRICS

Fyn inhibition by TAE684: A synergistic strategy to suppress melanoma and reverse vemurafenib resistance.

Autori: Liu, Waner Zhang, Xu Liang, Xiaowei a ďalší

Zdroj: Cell Death & Disease; 11/6/2025, Vol. 16 Issue 1, p1-14, 14p

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study).

Autori: Alhejazi, Ayman Alhuraiji, Ahmad Nourallah, Abdulnaser a ďalší

Zdroj: Frontiers in Oncology; 2025, p1-13, 13p

Predmety: PLASMA cells, STEM cell transplantation, MULTIPLE myeloma, LENALIDOMIDE, DARATUMUMAB

Geografický termín: PERSIAN Gulf

Exploring health disparities in diagnosing multiple myeloma.

Autori: Ghalehsari, Nima Zahid, Sofia Main, Olivia a ďalší

Zdroj: Expert Review of Hematology; Oct2024, Vol. 17 Issue 10, p749-753, 5p

Long‐term immune changes after COVID‐19 and the effect of BCG vaccination and latent infections on disease severity.

Autori: Bendíčková, Kamila Papatheodorou, Ioanna Blažková, Gabriela a ďalší

Zdroj: Clinical & Translational Immunology; 2025, Vol. 14 Issue 7, p1-19, 19p

Predmety: COVID-19, BCG vaccines, SEVERITY of illness index, SEPSIS, LATENT infection, IMMUNE response, MYELOID cells

Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma.

Autori: Bumma, Naresh Dhakal, Binod Fraser, Raphael a ďalší

Zdroj: Cancer (0008543X); Jul2023, Vol. 129 Issue 14, p2179-2191, 13p

Predmety: MULTIPLE myeloma, LENALIDOMIDE, STEM cell transplantation, CLINICAL trials, OVERALL survival

Inhibition of NLRP3 enhances pro-apoptotic effects of FLT3 inhibition in AML.

Autori: Sieberer, Helene Luciano, Michela Amend, Diana a ďalší

Zdroj: Cell Communication & Signaling; 1/28/2025, Vol. 23 Issue 1, p1-11, 11p

Predmety: ACUTE myeloid leukemia, MEDICAL sciences, COMBINATION drug therapy, NLRP3 protein, CELL cycle

The Lagrange Identity and Dynamics in a Potential Jacobi Field.

Autori: Kozlov, Valery V.

Zdroj: Regular & Chaotic Dynamics; Dec2025, Vol. 30 Issue 6, p887-907, 21p

CD39 and CD73: biological functions, diseases and therapy.

Autori: Shen, Jie Liao, Bin Gong, Li a ďalší

Zdroj: Molecular Biomedicine; 11/5/2025, Vol. 6 Issue 1, p1-38, 38p

Predmety: DRUG target, CANCER treatment, ADENOSINE triphosphatase, PURINERGIC receptors, IMMUNOREGULATION, PATHOGENESIS

Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting database.

Autori: Jiang, Tingting Li, Yanping Zhang, Ni a ďalší

Zdroj: Therapeutic Advances in Drug Safety; 2025 Suppl 1, Vol. 16, p1-20, 20p

Effect of high‐flow oxygen therapy on regional oxygen saturation during vaso‐occlusive pain crisis: An observational study.

Autori: Gendreau, Segolene Cecchini, Jérôme Perier, François a ďalší

Zdroj: British Journal of Haematology; Jun2023, Vol. 201 Issue 6, pe58-e61, 4p

Predmety: OXYGEN saturation, OXYGEN therapy, COMPLEX regional pain syndromes, RED blood cell transfusion

Adverse events in the nervous system associated with blinatumomab: a real-world study.

Autori: Gao, Wen Yu, Jingwei Sun, Yifei a ďalší

Zdroj: BMC Medicine; 2/6/2025, Vol. 23 Issue 1, p1-12, 12p

Predmety: CYTOKINE release syndrome, INTRACRANIAL pressure, BISPECIFIC antibodies, DEATH rate, NERVOUS system

Korporácia: UNITED States. Food & Drug Administration

Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model

Autori: Willemin, Marie-Emilie Gong, Jue Hilder, Brandi W. a ďalší

Zdroj: Targeted Oncology; Nov2024, Vol. 19 Issue 6, p965-979, 15p

Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase.

Autori: Haddad, Fadi G. Sasaki, Koji Nasr, Lewis a ďalší

Zdroj: Cancer (0008543X); Oct2024, Vol. 130 Issue 19, p3344-3352, 9p

Predmety: CHRONIC myeloid leukemia, PROTEIN-tyrosine kinase inhibitors, CARDIOTOXICITY, OVERALL survival, SURVIVAL rate

Olverembatinib combined with blinatumomab in treating T315I-mutated Philadelphia chromosome–positive acute lymphoblastic leukemia: two-case report.

Autori: Fan, Shengxuan Wang, Lina Lu, Yaoyao a ďalší

Zdroj: Annals of Hematology; Feb2024, Vol. 103 Issue 2, p525-532, 8p

Predmety: LYMPHOBLASTIC leukemia, ACUTE leukemia, CHRONIC myeloid leukemia, PROTEIN-tyrosine kinase inhibitors, THERAPEUTICS

Geografický termín: CHINA

Integration of Immunotherapy Into the Frontline Treatment of Acute Lymphoblastic Leukemia.

Autori: Dias, Ajoy Litzow, Mark R.

Zdroj: Clinical Advances in Hematology & Oncology; Sep2025, Vol. 23 Issue 6, p350-360, 11p

Importance of Retinoic Acid Derivatives in Breast Cancer: A Literature Review.

Autori: J. P., MAGESH KIRUBAKARAN SHRIVASTAV, POOJA RAVICHANDRAN, SANGEETHA a ďalší

Zdroj: Journal of Clinical & Diagnostic Research; Sep2025, Vol. 19 Issue 9, p1-6, 6p

Predmety: BREAST cancer, CANCER treatment, HOMEOBOX genes, TAMOXIFEN, TRETINOIN, TREATMENT effectiveness, DRUG resistance in cancer cells, CELL differentiation

Derivation of a novel multi‐gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.

Autori: Ahmadi, Ali Navidinia, Amir Abas Bashash, Davood a ďalší

Zdroj: PLoS ONE; 8/1/2025, Vol. 20 Issue 8, p1-17, 17p

Predmety: ACUTE myeloid leukemia, PROGNOSTIC models, GENE expression, IMMUNE response, CELL death, TREATMENT failure, BIOINFORMATICS, DNA mutational analysis

Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect.

Autori: Perrone, Salvatore Imperatore, Stefano Sucato, Giuseppe a ďalší

Zdroj: Annals of Hematology; Nov2023, Vol. 102 Issue 11, p3025-3030, 6p

Predmety: INTRACRANIAL hemorrhage, INTRACEREBRAL hematoma, EXPOSURE dose, ACUTE myeloid leukemia, DATABASES

Kinetic properties of E-NTPDase activity in lymphocytes isolated from bone marrow, thymus and mesenteric lymph nodes of Wistar rats.

Autori: Doleski, Pedro Henrique Cabral, Fernanda Licker Jantsch, Matheus Henrique a ďalší

Zdroj: Molecular & Cellular Biochemistry; Sep2024, Vol. 479 Issue 9, p2447-2458, 12p